PURPOSE
Parkinson's disease (PD) has a high incidence of psychiatric comorbidity, specifically depression and anxiety. This study examined the effectiveness of group cognitive behavioral therapy (CBT) in treating depression and anxiety.
METHODS
The study included 42 participants, aged between 52 and 77 years, who were diagnosed with idiopathic Parkinson's disease (IPD) and reported suffering from depression and anxiety. Patients were attending a department of outpatient neurology at D University Schools of Medicine in B Metropolitan city. A structured telephone-administered cognitive behavioral therapy was conducted for eight weeks. A repeated measure ANOVA was used to analyze results at pretest, post-test, and four weeks follow up.
RESULTS
According to service method, there were significant differences between the two groups in depression, anxiety and stigma was significant difference between time (p<.05). Analysis of the interaction between time and service method revealed significant differences in depression and anxiety (p<.05).
CONCLUSION
The results suggest that telephoneadministered cognitive behavioral therapy may be effective and may provide opportunity to adapt to individual needs for treating depression and anxiety in patients with Parkinson's disease.

Citations

• Efficacy of cognitive behavioral therapy for anxiety and depression in Parkinson’s disease patients: an updated systematic review and meta-analysis
  Asmaa Zakria Alnajjar, Moaz Elsayed Abouelmagd, Abdulrahman Krayim, Maickel AbdelMeseh, Nagham Bushara, Yehia Nabil
  Neurological Sciences.2024; 45(11): 5277.     CrossRef
• Effects of Task-Based LSVT-BIG Intervention on Hand Function, Activity of Daily Living, Psychological Function, and Quality of Life in Parkinson’s Disease: A Randomized Control Trial
  YoungSeok Choi, DeokJu Kim, Kuan Lin Chen
  Occupational Therapy International.2022; 2022: 1.     CrossRef
• Concept Analysis of Self-stigma in Patients with Tuberculosis
  Seonmi Yeom, Jeong Hee Kang, Youngran Yang
  Journal of Korean Academy of Community Health Nursing.2021; 32(3): 312.     CrossRef
• Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment
  Jianing Chen, Peikun He, Yuhu Zhang, Yuyuan Gao, Yihui Qiu, You Li, Qingxi Zhang, Limin Wang, Zhiheng Huang, Jiehao Zhao, Kun Nie, Lijuan Wang
  International Journal of Neuroscience.2021; 131(4): 411.     CrossRef
• Personalized Telemedicine for Depression in Parkinson’s Disease: A Pilot Trial
  Roseanne D. Dobkin, Alejandro Interian, John Logan Durland, Michael A. Gara, Matthew A. Menza
  Journal of Geriatric Psychiatry and Neurology.2018; 31(4): 171.     CrossRef
• Factors that affect Chronic Illness Anticipated Stigma(CIAS) in patients with Parkinson's disease
  Mi-Jung Kim, Eun-Sook Bae
  Korean Journal of Health Education and Promotion.2015; 32(3): 121.     CrossRef

PURPOSE
The purpose of this study was to examine the effects of a cognitive behavioral stress management program on diabetic self-care and glycemic control with type 2 diabetic patients.
METHODS
Thirty three diabetic patients who were older than 40 were recruited from a public health center and conveniently assigned into both experimental(n=16) and control groups(n=17). Participants in the experimental group had attended the weekly cognitive behavioral program for 8 weeks. Data were collected from June 2005 to August 2006 and analyzed by independent t-test using the SPSS WIN program.
RESULTS
After an 8 week intervention, participants in the experimental group reported on increasement of diabetic self-care behaviors and an increasement of blood glucose levels, which were significantly different from those in the control group.
CONCLUSION
On the basis of those findings, we concluded that the cognitive behavioral stress management program has positive effects on diabetic self-care and glycemic control for the patients with DM. Further research is needed to identify the long-term effects of the cognitive behavioral program.